Published in Nature on October 27, 1988
In vivo induction of anergy in peripheral V beta 8+ T cells by staphylococcal enterotoxin B. J Exp Med (1990) 2.69
Selective anergy of V beta 8+,CD4+ T cells in Staphylococcus enterotoxin B-primed mice. J Exp Med (1990) 2.47
The appearance of T cells bearing self-reactive T cell receptor in the livers of mice injected with bacteria. J Exp Med (1991) 1.99
Tolerance-related V beta clonal deletions in normal CD4-8-, TCR-alpha/beta + and abnormal lpr and gld cell populations. J Exp Med (1989) 1.83
A third T-cell receptor beta-chain variable region gene encodes reactivity to Mls-1a gene products. Proc Natl Acad Sci U S A (1989) 1.68
Direct binding of secreted T-cell receptor beta chain to superantigen associated with class II major histocompatibility complex protein. Proc Natl Acad Sci U S A (1991) 1.46
An exogenous mouse mammary tumor virus with properties of Mls-1a (Mtv-7). J Exp Med (1992) 1.45
Estrogen administration activates extrathymic T cell differentiation in the liver. J Exp Med (1992) 1.38
Increased frequency of T cell receptor V alpha 12.1 expression on CD8+ T cells: evidence that V alpha participates in shaping the peripheral T cell repertoire. J Exp Med (1991) 1.33
Identification and characterization of new murine T cell receptor beta chain variable region (V beta) genes. J Exp Med (1989) 1.26
Defect in negative selection in lpr donor-derived T cells differentiating in non-lpr host thymus. J Exp Med (1991) 1.16
Selective decreases in T cell receptor V beta expression. Decreased expression of specific V beta families is associated with expression of multiple MHC and non-MHC gene products. J Exp Med (1989) 1.08
Characterization of the ligand(s) responsible for negative selection of V beta 11- and V beta 12-expressing T cells: effects of a new Mls determinant. J Exp Med (1990) 1.05
The T cell receptor repertoire influences V beta element usage in response to myoglobin. J Exp Med (1991) 1.04
Intrathymic clonal deletion of V beta 6+ T cells in cyclophosphamide-induced tolerance to H-2-compatible, Mls-disparate antigens. J Exp Med (1990) 1.01
Analysis of Mlsc genetics. A novel instance of genetic redundancy. J Exp Med (1989) 0.92
Profound alteration in an alpha beta T-cell antigen receptor repertoire due to polymorphism in the first complementarity-determining region of the beta chain. Proc Natl Acad Sci U S A (1991) 0.91
Molecular analysis of the influences of positive selection, tolerance induction, and antigen presentation on the T cell receptor repertoire. J Exp Med (1990) 0.89
T cell receptor-mediated recognition of self-ligand induces signaling in immature thymocytes before negative selection. J Exp Med (1992) 0.84
Positive selection of a T-cell subpopulation in the thymus in which it develops. Proc Natl Acad Sci U S A (1989) 0.83
Bacterial and viral superantigens: roles in autoimmunity? Ann Rheum Dis (1993) 0.83
Clonal deletion of self-Mls-reactive thymocytes at the early stage in H-2-compatible but Mls-disparate radiation chimeras. Immunology (1990) 0.81
Identification of a limited T-cell receptor beta chain variable region repertoire associated with diabetes in the BB rat. Proc Natl Acad Sci U S A (1991) 0.80
Different expression of T-cell receptor beta-chain variable region genes in lymph nodes of lpr mice with different alleles of the major histocompatibility complex. Immunology (1990) 0.78
Unresponsiveness to Mlsa induced in newborn Mlsb mice by maternal preimmunization. Immunology (1991) 0.78
Expression of mouse mammary tumor virus superantigen accelerates tumorigenicity of myeloma cells. J Virol (2000) 0.75
A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation. N Engl J Med (1992) 6.06
The tissue distribution of the B7-2 costimulator in mice: abundant expression on dendritic cells in situ and during maturation in vitro. J Exp Med (1994) 3.66
Identification of an alternative CTLA-4 ligand costimulatory for T cell activation. Science (1993) 3.49
Comparative analysis of B7-1 and B7-2 costimulatory ligands: expression and function. J Exp Med (1994) 3.24
Uncovering of functional alternative CTLA-4 counter-receptor in B7-deficient mice. Science (1993) 2.78
Human naive and memory T lymphocytes differ in telomeric length and replicative potential. Proc Natl Acad Sci U S A (1995) 2.77
Cellular and genetic control of antibody responses. V. Helper T-cell recognition of H-2 determinants on accessory cells but not B cells. J Exp Med (1979) 2.75
Glucocorticoids in T cell development and function*. Annu Rev Immunol (2000) 2.63
Regulated expression of telomerase activity in human T lymphocyte development and activation. J Exp Med (1996) 2.60
Presumptive identification of streptococci with a new test system. J Clin Microbiol (1982) 2.55
Cellular and genetic control of antibody responses in vitro. I. Cellular requirements for the generation of genetically controlled primary IgM responses to soluble antigens. Eur J Immunol (1977) 2.47
Self recognition in allogeneic radiation bone marrow chimeras. A radiation-resistant host element dictates the self specificity and immune response gene phenotype of T-helper cells. J Exp Med (1981) 2.39
The cell-surface proteoglycan Dally regulates Wingless signalling in Drosophila. Nature (1999) 2.22
Disseminated intravascular coagulation and the Waterhouse-Friderichsen syndrome. Arch Dis Child (1971) 2.15
Tales of tails: regulation of telomere length and telomerase activity during lymphocyte development, differentiation, activation, and aging. Immunol Rev (1997) 2.13
Regulation of immunostimulatory function and costimulatory molecule (B7-1 and B7-2) expression on murine dendritic cells. J Immunol (1994) 2.09
Cellular and genetic control of antibody responses in vitro. IV. Expression of Ia antigens on accessory cells required for responses to soluble antigens including a response under Ir gene control. J Immunol (1978) 2.04
Cellular and genetic control of antibody responses in vitro. III. Immune response gene regulation of accessory cell function. J Exp Med (1978) 1.99
Mercuric reductase. Purification and characterization of a transposon-encoded flavoprotein containing an oxidation-reduction-active disulfide. J Biol Chem (1982) 1.95
Telomere lengthening and telomerase activation during human B cell differentiation. Proc Natl Acad Sci U S A (1997) 1.93
Increased incidence of abnormal nasal cilia in patients with retinitis pigmentosa. Nature (1979) 1.87
Inhibition of transplant rejection following treatment with anti-B7-2 and anti-B7-1 antibodies. Transplantation (1995) 1.82
Murine B7-2, an alternative CTLA4 counter-receptor that costimulates T cell proliferation and interleukin 2 production. J Exp Med (1993) 1.81
A virus-encoded "superantigen" in a retrovirus-induced immunodeficiency syndrome of mice. Science (1991) 1.80
Telomere length regulation in mice is linked to a novel chromosome locus. Proc Natl Acad Sci U S A (1998) 1.78
Structural analysis of glycosaminoglycans in animals bearing mutations in sugarless, sulfateless, and tout-velu. Drosophila homologues of vertebrate genes encoding glycosaminoglycan biosynthetic enzymes. J Biol Chem (2000) 1.61
The central issue? Visceral fat mass is a good marker of insulin resistance and metabolic disturbance in women with polycystic ovary syndrome. BJOG (2006) 1.60
Evidence for possible involvement of an elastolytic serine protease in aspergillosis. Infect Immun (1993) 1.58
Synergy between subpopulations of mouse spleen cells in the in vitro generation of cell-mediated cytotoxicity: evidence for the involvement of a non-T cell. J Exp Med (1974) 1.58
In vitro generation of suppressor cell activity: suppression of in vitro induction if cell-mediated cytotoxicity. J Immunol (1976) 1.55
The T cell repertoire for recognition of a phylogenetically distant protein antigen. Peptide specificity and MHC restriction of staphylococcal nuclease-specific T cell clones. J Exp Med (1986) 1.55
Lineage-specific telomere shortening and unaltered capacity for telomerase expression in human T and B lymphocytes with age. J Immunol (2000) 1.52
Telomere length, telomerase activity, and replicative potential in HIV infection: analysis of CD4+ and CD8+ T cells from HIV-discordant monozygotic twins. J Exp Med (1997) 1.50
Mechanisms of T cell-B cell interaction. Annu Rev Immunol (1983) 1.47
A brief spiritual beliefs inventory for use in quality of life research in life-threatening illness. Psychooncology (1999) 1.44
Phase 1/2 trial of autologous tumor mixed with an allogeneic GVAX vaccine in advanced-stage non-small-cell lung cancer. Cancer Gene Ther (2006) 1.43
T-cell recognition of minor lymphocyte stimulating (Mls) gene products. Annu Rev Immunol (1989) 1.43
Constitutive and regulated expression of telomerase reverse transcriptase (hTERT) in human lymphocytes. Proc Natl Acad Sci U S A (1999) 1.42
Requirement for an Ia-bearing accessory cell in Con A-induced T cell proliferation. J Immunol (1978) 1.41
Regulation of telomere length and telomerase in T and B cells: a mechanism for maintaining replicative potential. Immunity (1998) 1.41
Insecticide-treated cattle for tsetse control: the power and the problems. Med Vet Entomol (2000) 1.39
Chronic eosinophilic pneumonia. Thorax (1980) 1.39
T cell regulation of b cell activation. Cloned Lyt-1+2-T suppressor cells inhibit the major histocompatibility complex-restricted interaction of T helper cells with B cells and/or accessory cells. J Exp Med (1983) 1.35
Variations in the ultrastructure of human nasal cilia including abnormalities found in retinitis pigmentosa. J Clin Pathol (1980) 1.28
Self recognition in allogeneic thymic chimeras. Self recognition by T helper cells from thymus-engrafted nude mice is restricted to the thymic H-2 haplotype. J Exp Med (1982) 1.27
Distinct B cell subpopulations differ in their genetic requirements for activation by T helper cells. Immunol Rev (1982) 1.26
IL-5 induces a Pgp-1 (CD44) bright B cell subpopulation that is highly enriched in proliferative and Ig secretory activity and binds to hyaluronate. J Immunol (1990) 1.24
Activation of B cells by autoreactive T cells: cloned autoreactive T cells activate B cells by two distinct pathways. J Immunol (1984) 1.24
Activation of the Lck tyrosine kinase targets cell surface T cell antigen receptors for lysosomal degradation. Immunity (1997) 1.22
Characterization of a novel cell-surface molecule expressed on subpopulations of activated T and B cells. J Immunol (1993) 1.20
Venous infarction of the adrenal glands. J Pathol (1976) 1.20
9-cis-retinoic acid inhibits activation-driven T-cell apoptosis: implications for retinoid X receptor involvement in thymocyte development. Proc Natl Acad Sci U S A (1993) 1.19
Multiple mechanisms of peripheral T cell tolerance to the fetal "allograft". J Immunol (1998) 1.19
CD44 expression on activated B cells. Differential capacity for CD44-dependent binding to hyaluronic acid. J Immunol (1993) 1.19
Induction of idiotype-bearing, nuclease-specific helper T cells by in vivo treatment with anti-idiotype. J Exp Med (1981) 1.18
Computed tomography of the brain in acute carbon monoxide poisoning. Clin Radiol (1996) 1.18
A targeted glucocorticoid receptor antisense transgene increases thymocyte apoptosis and alters thymocyte development. Immunity (1995) 1.17
Recombinase-activating gene (RAG) 2-mediated V(D)J recombination is not essential for tumorigenesis in Atm-deficient mice. Proc Natl Acad Sci U S A (2000) 1.17
Regulation of telomerase RNA template expression in human T lymphocyte development and activation. J Immunol (1997) 1.17
Mast cells in the human alveolar wall: an electronmicroscopic study. J Clin Pathol (1981) 1.16
T cell responses to Mls determinants are restricted by cross-reactive MHC determinants. J Immunol (1985) 1.16
Major histocompatibility complex-restricted self recognition. A monoclonal anti-I-Ak reagent blocks helper T cell recognition of self major histocompatibility complex determinants. J Exp Med (1980) 1.14
Expression of a microinjected porcine class I major histocompatibility complex gene in transgenic mice. Science (1985) 1.12
Liquid paraffin pneumonia--with chemical analysis and electronmicroscopy. Virchows Arch A Pathol Anat Histol (1979) 1.11
Productive infection of neonatal CD8+ T lymphocytes by HIV-1. J Exp Med (1998) 1.11
Characterization of autoantibody-secreting B cells in mice undergoing stimulatory (chronic) graft-versus-host reactions. Identification of a CD44hi population that binds specifically to hyaluronate. J Immunol (1991) 1.11
Influence of T cell receptor V alpha expression on Mlsa superantigen-specific T cell responses. J Exp Med (1992) 1.11
Effects of scopolamine on delayed-matching-to-sample and paired associates tests of visual memory and learning in human subjects: comparison with diazepam and implications for dementia. Psychopharmacology (Berl) (1997) 1.10
Blood pressure and respiratory patterns during human coitus. J Reprod Fertil (1969) 1.09
Regulatory mechanisms in cell-mediated immune responses. II. Comparison of culture-induced and alloantigen-induced suppressor cells in MLR and CML. J Immunol (1977) 1.09
Selective decreases in T cell receptor V beta expression. Decreased expression of specific V beta families is associated with expression of multiple MHC and non-MHC gene products. J Exp Med (1989) 1.08
Rabies with myocarditis. Two cases in England. Lancet (1970) 1.08
T cell regulation of B cell activation. T cells independently regulate the responses mediated by distinct B cell subpopulations. J Exp Med (1982) 1.08
Preferential V beta usage by cytotoxic T cells cross-reactive between two epitopes of HIV-1 gp160 and degenerate in class I MHC restriction. J Immunol (1993) 1.08
Differential regulation of interleukin 4 and interleukin 5 gene expression: a comparison of T-cell gene induction by anti-CD3 antibody or by exogenous lymphokines. Proc Natl Acad Sci U S A (1990) 1.08
T cell recognition in the mixed lymphocyte response. I. Non-T, radiation-resistant splenic adherent cells are the predominant stimulators in the murine mixed lymphocyte reaction. J Immunol (1979) 1.07
Ontogeny of murine accessory cells: Ia antigen expression and accessory cell function in in vitro primary antibody responses. J Immunol (1980) 1.07
Cytotoxic T lymphocyte responses by chimeric thymocytes. Self-recognition is determined early in T cell development. J Exp Med (1981) 1.07
T cell regulation of B cell activation. I-A-restricted T suppressor cells inhibit the major histocompatibility complex-restricted interactions of T helper cells with B cells and accessory cells. J Exp Med (1983) 1.06
Distribution of fatty and fibrous plaques in young human coronary arteries. Atherosclerosis (1982) 1.05
Characterization of the ligand(s) responsible for negative selection of V beta 11- and V beta 12-expressing T cells: effects of a new Mls determinant. J Exp Med (1990) 1.05
On the specificity of cell-mediated cytotoxicity in vitro. Cell Immunol (1970) 1.05
T cell recognition of Mlsc. I. Influence of MHC gene products in Mlsc-specific T cell recognition. J Immunol (1988) 1.04
The role of B7 costimulation in CD4/CD8 T cell homeostasis. J Immunol (2000) 1.02
Carcinoma of the lung and diffuse interstitial pulmonary fibrosis. J Clin Pathol (1968) 1.02
Sequences outside a minimal immunodominant site exert negative effects on recognition by staphylococcal nuclease-specific T cell clones. J Immunol (1989) 1.02
Adrenal haemorrhage and necrosis resulting from abdominal operations. Lancet (1969) 1.01
Immunomodulation in patients receiving intravenous Bryostatin 1 in a phase I clinical study: comparison with effects of Bryostatin 1 on lymphocyte function in vitro. Cancer Immunol Immunother (1994) 1.00
Fatal Lyme carditis and endodermal heterotopia of the atrioventricular node. Postgrad Med J (1990) 1.00
The Mls system: non-MHC genes that encode strong T-cell stimulatory determinants. Immunol Today (1989) 1.00
Cytotoxic potential of different lymphoid cell populations against chromium-51 labelled tumour cells. Clin Exp Immunol (1969) 1.00
Specific cytotoxicity of H-2-incompatible mouse lymphocytes following mixed culture in vitro. Transplantation (1970) 0.99